NeurAxis, Inc. (NRXS) Stock: Dividends & Earnings

Company Overview:

Market Cap: $84.76M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $2.21 - $9.33

3.2 Year NRXS Performance Metrics:

Total Return (with DRIP): 12.5% (3.75% CAGR)

Total Return (no DRIP): 12.5% (3.75% CAGR)

Share Price: 12.5% (3.75% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $11,250

Total Return $ (with DRIP): $1,250

NRXS Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

NRXS Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Projected Future Returns & Dividends for NRXS

Based on past 3.2-year performance, here are NRXS growth metrics:

Share price CAGR of +3.75%
Dividend CAGR of +0%

Using NRXS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	NRXS (DRIP)	NRXS - No DRIP
Current Price	$6.75	$6.75
Start Shares	1,481.48	1,481.48
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,481.48	1,481.48
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$6.75	$6.75
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - NRXS

NOTE: Above numbers are our estimate based on NRXS's Dividend and Price CAGR over past 3.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

NeurAxis, Inc. (NRXS) had its IPO on , and is traded on NYSE stock exchange.

NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies for chronic and debilitating conditions, with an emphasis on disorders of the gut-brain interaction. Its current product portfolio centers on IB-Stim, a drug-free, non-surgical device worn behind the ear and designed to deliver percutaneous electrical nerve field stimulation for patients with functional abdominal pain associated with irritable bowel syndrome, functional dyspepsia, and related nausea symptoms. The company serves pediatric and adult patients through healthcare settings such as hospitals and clinics, where its therapies are used to support symptom management in targeted gastrointestinal conditions. NeurAxis also works to commercialize evidence-based devices that address unmet needs in digestive health and related neuromodulation care. Headquartered in Carmel, Indiana, NeurAxis operates as a specialized player in the medical device market with a focus on non-invasive treatment options.

NRXS website: https://neuraxis.com